 |
 |
 |
||||||
 |
||||||||
 |
 |
 |
 |
|||||
 |
 |
 |
|
|||||
|
|
|
|
|
|
|
|
|
 |
 |
|
 |
2005 Press Archive | |
|
2004 Press Archive | |
|
2003 Press Archive | |
|
2002 Press Archive | |
|
2001 Press Archive | |
|
2000 Press Archive | |
 |
|
|
Press Releases - 2006
2006 Press Releases
December 12
Sangamo BioSciences and City of Hope Announce License Agreement and Research Collaboration to Develop Treatment for Brain Cancer
December 7
Sangamo BioSciences Provides Update on Company's Accomplishments in 2006 and Objectives for Next 12 Months
December 4
Edwards' Angiogenesis Program to Be Acquired by Sangamo
November 30
Sangamo BioSciences to Webcast Presentations at Investor and Analyst Briefing
November 29
Sangamo BioSciences Initiates Phase 2 Clinical Trial of Novel Therapy for Diabetic Neuropathy
November 27
Sangamo BioSciences to Present at the Piper Jaffray Health Care Conference
November 16
Dow AgroSciences and Sangamo BioSciences Announce the Achievement of Multiple Milestones in Their Plant Agriculture Collaboration
November 9
Sangamo BioSciences to Present at the JMP Securities Healthcare Conference
November 1
Sangamo BioSciences to Present at the Rodman and Renshaw 8th Annual Healthcare Conference
October 30
Sangamo BioSciences Corrects Third Quarter 2006 Financial Results
October 30
Sangamo BioSciences Reports 2006 Third Quarter Financial Results
October 26
Sangamo BioSciences and JDRF Announce Partnership for ZFP Therapeutic for Diabetic Neuropathy Program
October 23
Sangamo BioSciences Announces Third Quarter 2006 Conference Call and Webcast
October 17
Sangamo BioSciences Announces Presentation of ZFP Therapeutic Data From Nerve Regeneration Program at Society for Neuroscience Meeting
October 13
Sangamo BioSciences to Present at the BIO Investor Forum
September 27
Sangamo BioSciences Announces Positive HIV/CCR5-ZFN Data in Presentation at 46th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy
September 18
Sangamo BioSciences to Present at the UBS Global Life Sciences Conference
September 18
Sangamo BioSciences Announces Presentation of ZFP Therapeutic Clinical Data From Diabetic Neuropathy Program at Major European Diabetes Meeting
July 27
Michael Gilman, Ph.D., Joins Sangamo BioSciences Scientific Advisory Board
July 25
Sangamo BioSciences Reports 2006 Second Quarter Financial Results
July 18
Sangamo BioSciences Announces Second Quarter 2006 Conference Call and Webcast
July 5
Sangamo BioSciences Added to Russell 3000 and 2000 Indexes
June 21
Sangamo BioSciences to Present at the Jefferies Life Sciences Conference
June 16
Sangamo BioSciences, Inc. Announces Common Stock Offering Raising Net Proceeds of $20.15 Million - Corrected Press Release
June 16
Sangamo BioSciences, Inc. Announces Common Stock Offering Raising Net Proceeds of $20.15 Million
June 15
Sangamo BioSciences, Inc. Announces Common Stock Offering
June 14
Sangamo BioSciences Announces Presentation of Data From ZFP Therapeutic(TM) Neurology Programs at Keystone Symposium
June 12
Sangamo BioSciences Announces 'Late-Breaking' Presentation of Phase 1b ZFP Therapeutic Data at American Diabetes Association Meeting
June 7
Sangamo Elects H. Ward Wolff to Board of Directors and Chair of Audit Committee
June 1
Sangamo BioSciences to Present Data From Its ZFP Therapeutic(TM) Programs at the 9th Annual Meeting of the American Society of Gene Therapy
May 26
Data From Sangamo BioSciences' Diabetic Neuropathy Program Published in Diabetes
May 10
Sangamo BioSciences to Present at Two Upcoming Investor Conferences
May 2
Sangamo BioSciences Presents Preclinical Data From ZFP Therapeutic for Age- Related Macular Degeneration
May 1
Sangamo BioSciences Reports 2006 First Quarter Financial Results
April 24
Sangamo BioSciences Announces First Quarter 2006 Conference Call and Webcast
April 6
Sangamo BioSciences Announces First Clinical Results From Trial of ZFP Therapeutic in Patients With Diabetic Neuropathy
March 23
Sangamo BioSciences to Present at the BioCentury Future Leaders in the Biotech Industry Conference
March 2
Sangamo BioSciences to Present at the 5th Annual JMP Securities Research Conference
March 2
Sangamo BioSciences Licenses MaxCyte Cell Loading Technology for ZFP Therapeutic Program for HIV/Aids
February 9
Sangamo BioSciences Reports 2005 Fourth Quarter and Year-End Financial Results
February 9
Sangamo BioSciences Announces HIV/CCR5 ZFP Therapeutic Data Presentation at 13th Conference on Retroviruses and Opportunistic Infections
February 7
Sangamo BioSciences to Present at BIO CEO & Investor Conference 2006
February 2
Sangamo BioSciences Announces Fourth Quarter and Year-end 2005 Conference Call and Webcast
January 25
Sangamo BioSciences Announces Publication of ZFP Therapeutic(TM) Data for Peripheral Artery Disease Program
January 12
Sangamo BioSciences Announces Plans for Phase 2 Clinical Trial of ZFP Therapeutic in Diabetic Neuropathy at JPMorgan Healthcare Conference
January 5
Sangamo BioSciences to Present at 24th Annual JPMorgan Healthcare Conference
January 4
Sangamo BioSciences Announces Expansion of Research Collaboration Agreement With Pfizer Inc
|
Contact |  |
Careers | |
Site Map | |
Legal | |
Glossary | |
|
|
|
|
|
|
|